A Study of Apatinib Plus EGFR-TKI as First Line Treatment in Patients With Non-squamous NSCLC Harboring EGFR Mutations
Clinical trial NCT03634059 · UNKNOWN
Trial details
- NCT number
- NCT03634059
- Sponsor
- Hebei Medical University Fourth Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-15
- Primary completion
- 2019-08-15
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.